Systemic macrophage migration inhibitory factor release following hepatic resection.

Area of Science:

• Hepatobiliary Surgery
• Immunology
• Surgical Oncology

Background:

• Macrophage migration inhibitory factor (MIF) is a key cytokine involved in immune regulation.
• Hepatic resection is a major surgical procedure with potential for significant physiological stress.
• The role of MIF in the context of hepatic resection and its impact on postoperative outcomes require further elucidation.

Purpose of the Study:

• To investigate the dynamic changes in serum MIF levels following hepatic resection.
• To explore the relationship between MIF, cortisol, and tumor necrosis factor-alpha (TNF-alpha) after liver surgery.
• To assess the predictive value of MIF for short-term postoperative morbidity and outcomes.

Main Methods:

• Serial blood sampling from 29 patients undergoing hepatic resection and 8 healthy volunteers over 24 hours.
• Assay of serum MIF, cortisol, and TNF-alpha levels.
• Correlation analysis and comparison of cytokine profiles across different hepatectomy extents (extended, lobectomy/segmentectomy, subsegmentectomy).

Main Results:

• Serum MIF and cortisol levels exhibited parallel increases post-hepatic resection, with significant correlation (r2 = 0.33, P = 0.0011).
• TNF-alpha levels also increased but did not correlate with MIF.
• No significant differences in MIF, cortisol, or TNF-alpha kinetics were observed among the different surgical groups; all patients had uncomplicated recoveries.

Conclusions:

• MIF is produced in response to hepatic resection, with surgical stress appearing to be a primary driver rather than inflammatory stimuli like TNF-alpha.
• MIF levels do not appear to significantly influence short-term postoperative morbidity or outcomes in patients undergoing hepatic resection.
• Further research may explore MIF's role in longer-term outcomes or in specific patient populations with complications.